Dart to the target: an alternative bull's eye parametric display for European Society of Cardiology / European Respiratory Society goal-orientated risk reduction strategy in pulmonary arterial hypertension

Pulmonary Circulation
Cihangir KaymazSeda Tanyeri

Abstract

Despite the significant mortality and mobidity benefits being obtained with the targeted therapies in patients with pulmonary arterial hypertension (PAH), mid- to long-term survival of patients with this disease has remained unsatisfactory. For earlier and reliable risk stratification in PAH and tailoring the dynamic management strategies, various risk assessment models have been developed. Currently available risk reduction strategy recommended by the European Society of Cardiology (ESC)/European Respiratory Society (ERS) 2015 Pulmonary Hypertension Guidelines has been utilized in three recent registries. In this review, we evaluated the risk prediction models and management algorithms in this setting and propose an alternative parametric display, a bull's eye, dart table scheme for ESC/ERS goal-orientated risk reduction strategy in patients with PAH.

References

Jan 30, 1992·Statistics in Medicine·L S FreedmanA Schatzkin
Feb 1, 1996·The New England Journal of Medicine·R J BarstUNKNOWN Primary Pulmonary Hypertension Study Group
Sep 3, 2002·Journal of the American College of Cardiology·Olivier SitbonGérald Simonneau
Sep 18, 2002·Circulation·Vallerie V McLaughlinStuart Rich
Jan 22, 2009·European Heart Journal·Nazzareno GalièAngelo Branzi
Jun 22, 2010·The European Respiratory Journal·M HumbertUNKNOWN French Pulmonary Arterial Hypertension Network
Sep 4, 2012·The European Respiratory Journal·Dave P MillerMarc Humbert
Oct 27, 2012·The European Respiratory Journal·Gianluigi SavaresePasquale Perrone-Filardi
Aug 30, 2013·The New England Journal of Medicine·Tomás PulidoUNKNOWN SERAPHIN Investigators
Oct 1, 2013·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Mardi Gomberg-MaitlandFernando Torres
Dec 21, 2013·Journal of the American College of Cardiology·Nazzareno GalièAnne Keogh
Apr 5, 2014·Chest·Mary G GeorgeShaleah Levant
Jun 22, 2014·Circulation·Corey E VentetuoloSteven M Kawut
Oct 15, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Harrison W FarberRaymond L Benza
Dec 3, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Raymond L BenzaMichael D McGoon
Apr 4, 2015·The European Respiratory Journal·Olivier SitbonMichael D McGoon
Jun 13, 2015·Chest·Harrison W FarberRaymond L Benza
Dec 25, 2015·The New England Journal of Medicine·Olivier SitbonP G Williams
Jun 24, 2017·European Heart Journal·Jason WeatheraldMarc Humbert
Aug 5, 2017·The European Respiratory Journal·Athénaïs BouclyOlivier Sitbon
Aug 5, 2017·The European Respiratory Journal·Raymond L BenzaMardi Gomberg-Maitland
Nov 28, 2017·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Murali M ChakinalaHarrison W Farber
Dec 11, 2017·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Raymond L BenzaMarius M Hoeper
Dec 20, 2017·American Journal of Respiratory and Critical Care Medicine·Jason WeatheraldOlivier Sitbon
Apr 7, 2018·The European Respiratory Journal·Clara HjalmarssonUNKNOWN SveFPH and SPAHR

❮ Previous
Next ❯

Methods Mentioned

BETA
RAP

Software Mentioned

COMPERA
SPAHR
EvalUation
REVEAL

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Infection
Guillaume BéraudNicolas Venisse
Current Opinion in Pulmonary Medicine
Carlos JardimRogerio Souza
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Gary L Schwartz
© 2022 Meta ULC. All rights reserved